| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/14/2008 | WO2008019302A1 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| 02/14/2008 | WO2008018892A2 Methods and kits for treating lacerations and puncture wounds using inverse thermosensitive polymers |
| 02/14/2008 | WO2008018592A1 External preparation comprising prostaglandin derivative |
| 02/14/2008 | WO2008018488A1 Antibacterial agent |
| 02/14/2008 | WO2008018450A1 Cell preparation containing multipotential stem cells originating in fat tissue |
| 02/14/2008 | WO2008018448A1 Activator comprising biosurfactant as the active ingredient, mannosyl erythritol lipid and method of producing the same |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018144A1 Moisturizing agent |
| 02/14/2008 | WO2008018143A1 Moisturizing agent |
| 02/14/2008 | WO2008018142A1 Antioxidant composition containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018141A1 Composition for preventing and/or treating itching containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018133A1 Moisturizing agent, cell-activating agent, skin-whitening agent, agent for suppressing triglyceride accumulation, antioxidant and external preparation for skin |
| 02/14/2008 | WO2008018106A1 Alpha lipoic acid combined with dimethylsulfoxide for tropical use |
| 02/14/2008 | WO2008017637A1 Drug combinations for the treatment of respiratory tract diseases |
| 02/14/2008 | WO2008017521A2 Compositions with enhanced elasticizing activity |
| 02/14/2008 | WO2007146897A3 The treatment of xerostomia |
| 02/14/2008 | WO2007113531A3 Topical drug delivery |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039907 Phototherapy Systems and Methods |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039524 reducing intraocular pressure in glaucoma; Methyl Ester of Methoxypolyethlene Glycol Thiol with DTPA; protect cells, tissues and organs against ionizing radiations, chemotherapy, degenerative diseases, or process that elicit the production of free radicals; remove Ca++, heavy metals |
| 02/14/2008 | US20080039522 Composition Containing a Complex Comprising a Metal Ion and a Carboxylate Ligand Having Anti-Inflammatory Activity |
| 02/14/2008 | US20080039519 Anti-Demodicosis Agent |
| 02/14/2008 | US20080039511 Thiazole Compound and Use Thereof |
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080039490 Pyridines for treating injured mammalian nerve tissue |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039424 Cosmetic composition comprising at least one polysaccharide chosen from lambda-carrageenans in combination with at least one non-ionic surface-active agent chosen from alkylpolyglucosides, and a method for the cosmetic treatment of keratinous fibers therewith |
| 02/14/2008 | US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 02/14/2008 | US20080039388 Derived from the chain of the (B)beta(15-42)-fibrin fragment substituted by genetically encoded or not genetically encoded amino acids or peptidomimetics; cysteine modified by succinimido-polyoxyethylene glycol; antiinflammatory agents; endothelium stabilizers |
| 02/14/2008 | US20080038388 extracting a plant extracts from Cucurbita pepo seed; applying on skin for increasing the skin synthesis of collagen; reducing the roughness of stretch-marked skin; enhancing elasticity, tone; prevent skin wrinkles |
| 02/14/2008 | US20080038381 Application of green tea extract and its major components in keloid scar therapy |
| 02/14/2008 | US20080038374 New Use |
| 02/14/2008 | US20080038372 Artificial Physiological Salt Solution and Manufacturing Method for Same |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038327 comprising S-sulfonated keratin associated with a water soluble polymer through hydrogen bonding and further comprising a protein cross-linking agent |
| 02/14/2008 | US20080038325 comprising biocompatible polymer, polyalcohol, and medicinal plant extract obtained from mixture of Houttuynia cordata, elm, persimmon leaves, celandine, pine tree leaves, Canavalia gladiata and an herb; prepared by irradiation to achieve crosslinking and three-dimensional structure; wound dressings |
| 02/14/2008 | US20080038313 Systems, methods, and compositions for mixing and applying lyophilized biomaterials |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038301 Personal care product comprising collapsible water-containing capsules |
| 02/14/2008 | US20080038300 Self-Adhesive Skin Patch and Combination Set for Cosmetic Skin Care |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038244 Materials and Methods Relating to Cell Cycle Control |
| 02/14/2008 | US20080038243 Wound healing compositions and methods using tropoelastin and lysyl oxidase |
| 02/14/2008 | US20080038223 WSX-1/P28 as a target for anti-inflammatory responses |
| 02/14/2008 | US20080038208 Pharmaceutical/cosmetic compositions comprising the lysine-d-proline-valine tripeptide |
| 02/14/2008 | DE20221822U1 Dünnflüssige, sprühbare W/O Emulsionen Low-viscosity, sprayable W / O emulsions |
| 02/14/2008 | CA2660349A1 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 02/14/2008 | CA2660186A1 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/14/2008 | CA2655472A1 Compositions with enhanced elasticizing activity |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886689A1 Oxidative stress inhibitor |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1886676A1 Compositions with enhanced elasticizing activity |
| 02/13/2008 | EP1885741A1 Lys-thr dipeptides and their use |
| 02/13/2008 | EP1885374A2 Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form |
| 02/13/2008 | EP1885373A2 Use of a clobetasol spray formulation for the treatment of psoriasis |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1885328A1 Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine |
| 02/13/2008 | EP1750735B1 Use of an extract of aloysia/verbrena/lippia triphylla/citridora for the preparation of a medicament for the treatment of chronic and/or inflammatory diseases |
| 02/13/2008 | EP1663195B1 Taurine bromamine for inhibiting pathogenic bacteria and fungi growth as well as in a microbicidal composition |
| 02/13/2008 | EP1572220B1 Antiviral properties of extracts of dichrostachys glomerata |
| 02/13/2008 | EP1543821B1 External preparation |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1476752A4 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1373234B1 Urokinase inhibitors |
| 02/13/2008 | EP1105467B9 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 02/13/2008 | EP1082126B1 Novel peptides |
| 02/13/2008 | CN101121753A Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell |
| 02/13/2008 | CN101120990A Medicine for treating eczema, urticaria and pruritus and using method |
| 02/13/2008 | CN101120987A Blood-nourishing speckle-removing powder and preparation method thereof |
| 02/13/2008 | CN101120986A Body-clearing itching-relieving liquid |
| 02/13/2008 | CN101120974A External-applied traditional Chinese medicine for treating scabies |
| 02/13/2008 | CN101120913A Ftibamzone chrisma with PEG-200 as co-solvent |
| 02/13/2008 | CN101120912A Ftibamzone chrisma with PEG-400 as co-solvent |
| 02/13/2008 | CN101120911A Ftibamzone chrisma with propanediol as co-solvent |
| 02/13/2008 | CN101120775A Face-nourishing health-care beverage |
| 02/13/2008 | CN100368540C Production method for recombinant cytoglobin and uses thereof |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368398C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100368012C Combined agent for treating alopecia areata, alopecia totalis and alopecia universalis |
| 02/13/2008 | CN100368004C Chinese medicinal composition for treating psoriasis, its preparation and quality control |
| 02/13/2008 | CN100367988C Chinese medicine for treating dermatomycosis and its preparing process |
| 02/13/2008 | CN100367973C Drying material and producing method thereof |
| 02/13/2008 | CN100367949C Melanin extinguisher |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |